| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/22/2009 | CA2705923A1 Antibodies to lrp6 |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705539A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | CA2705294A1 Method of treating arthritis |
| 05/21/2009 | US20090131949 delivering a bone substitue, water combinable combination of a calcium phosphate and a strontium phosphate and a salt of H3PO4; cement system for filling bone defects in a form-fit manner where the cement preparations are hardenable not only at room temperature, but also at body temperature; osteoporosis |
| 05/21/2009 | US20090131513 Anti-inflammatory modalities |
| 05/21/2009 | US20090131502 Biologically active compounds |
| 05/21/2009 | US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131443 Method for prevention and/or treatment of rheumatoid arthritis |
| 05/21/2009 | US20090131442 Method of Treating Bone Pain Caused by Osteoarthritis |
| 05/21/2009 | US20090131432 type II diabetes mellitus and obesity; dipeptidylpeptidase-IV (DPP-IV) inhibitor; 1-[2-(2-formylaminophenyl)-2-oxoethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-(3-aminopiperidin-1-yl)xanthine (xanthine=3,7-dihydro-purine-2,6-dione) |
| 05/21/2009 | US20090131424 Thiazolyl-dihydro-chinazoline |
| 05/21/2009 | US20090131408 Organic Compounds |
| 05/21/2009 | US20090131387 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/21/2009 | US20090131382 Treatment of rheumatoid arthritis using imatinib |
| 05/21/2009 | US20090131379 Vitamin d receptor activators and methods of making |
| 05/21/2009 | US20090131378 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 05/21/2009 | US20090131361 Novel Use of MLN51 Gene and Protein |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130192 Class iii slrp agonists for the reduction of blood vessel formation |
| 05/21/2009 | US20090130191 Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin |
| 05/21/2009 | US20090130122 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 05/21/2009 | US20090130113 Compositions and methods for use for antibodies against sclerostin |
| 05/21/2009 | US20090130078 Treatment for Cardiovascular Disease |
| 05/21/2009 | US20090130072 Use of Lactobacillus Kefiranofaciens as a Probiotic and a Synbiotic |
| 05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 05/20/2009 | EP2060300A1 C-19 steroids for therapeutic uses |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2060256A1 Pharmaceutical and nutraceutical compositions based on menaquinols |
| 05/20/2009 | EP2059512A1 P38 kinase inhibitors |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease |
| 05/20/2009 | CN101437934A Method of producing dry yeast containing S-adenosyl-L-methionine and composition for oral intake |
| 05/20/2009 | CN101437533A Antisecretory protein for use in the treatment of compartment syndrome |
| 05/20/2009 | CN101437527A Hyaluronic acid binary mixture and treatment purpose thereof |
| 05/20/2009 | CN101434656A Preparation and use of OPG-HSP70 fusion protein |
| 05/20/2009 | CN101434648A Peptide for inhibiting angiogenesis, and use thereof in angiogenesis medicament preparation |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433698A Chinese medicament preparation for reunion of bone |
| 05/20/2009 | CN101433665A Medicament for treating femoral head necrosis and preparation method thereof |
| 05/20/2009 | CN101433651A Plaster for treating painful swelling |
| 05/20/2009 | CN101433647A Plaster for treating femoral head necrosis and preparation method thereof |
| 05/20/2009 | CN101433605A External-use Chinese medical ointment for treating limb paralysis induced by wind-cold-dampness |
| 05/20/2009 | CN101433603A Method for producing medicament for treating hyperosteogeny |
| 05/20/2009 | CN101433600A Chinese medicinal composition for treating ostarthritis and preparation method thereof |
| 05/20/2009 | CN101433572A Herbal preparation for joints |
| 05/20/2009 | CN101433544A External-use pharmaceutical composition formulation with antiphlogistic, swelling-dispersing and analgesic functions, and use |
| 05/20/2009 | CN100488980C Integrin binding motif containing peptides and its uses |
| 05/20/2009 | CN100488526C Oral preparation |
| 05/20/2009 | CN100488524C Medicine for treating osteoporosis containing astraglus base and stanozolol |
| 05/20/2009 | CN100488508C Pharmaceutical composition containing tetrahydroisoquinoline compounds |
| 05/20/2009 | CN100488495C A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same |
| 05/20/2009 | CN100488372C Method for preparing bone-strengthening kidney-benefiting fatigue-alleviating soybean milk powder with micron deer bone powder, dragon's bone powder, pine pollen and king solomonseal rhizome powder |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534792 Pyrrolotriazine kinase inhibitors |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534436 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | US7534419 Calibration using chaperone protein |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2375017C Hydrochloride of fused-heterocycle compound |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/19/2009 | CA2206657C Therapeutic preparation for inhalation containing parathyroid hormone, pth |
| 05/14/2009 | WO2009062059A2 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
| 05/14/2009 | WO2009061516A1 Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening |
| 05/14/2009 | WO2009061336A1 Amorphous and crystalline forms of ibandronate disodium |
| 05/14/2009 | WO2009061271A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2009060608A1 Sustained release composition containing sdf-1 |
| 05/14/2009 | WO2009060278A1 Cyclobutyl carboxylic acid derivatives |
| 05/14/2009 | WO2009037190A3 Pharmaceutical formulation for il-ir antibody |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 05/14/2009 | US20090124674 Method for treating congestive heart failure |
| 05/14/2009 | US20090124673 Method for treating diabetic nephropathy |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124638 Anti-inflammatory pyrazolopyrimidines |
| 05/14/2009 | US20090124590 Pharmaceutical composition |
| 05/14/2009 | US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/14/2009 | US20090124580 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades |
| 05/14/2009 | US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 05/14/2009 | US20090124551 Methods of administering bone health compositions derived from milk |
| 05/14/2009 | US20090124550 Thrombin peptide derivative dimers |
| 05/14/2009 | US20090124537 Screening method for bone morphogenetic mimetics |
| 05/14/2009 | US20090123927 Isolation of precursor cells and their use for tissue repair |
| 05/14/2009 | US20090123566 Use of a phosphate adsorbent to combat vascular diseases |
| 05/14/2009 | US20090123516 Drug delivery from implants using self-assembled monolayers-therapeutic sams |
| 05/14/2009 | US20090123510 Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening |
| 05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |